Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07177677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder

Study acronym: ASD
StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This clinical trial aims to evaluate the safety and preliminary efficacy of intravenous administration of human bone marrow-derived mesenchymal stem cells (hBMMSCs) in patients with autism spectrum disorder (ASD).
Trial Details
NCT Number NCT07177677
Lead Sponsor Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
Collaborators: Capital Medical University
Conditions
(from sponsor)		 Autism Spectrum Disorder
Related terms Autism Spectrum Disorder
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov